Results
Kilitch Drugs FY26 Net Profit Rises 4% to ₹32.4 Crore
Kilitch Drugs approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, with auditors issuing unmodified opinions.
Standalone FY26 net profit increased to ₹32.
